Heartburn: Difference between revisions
imported>OAbot m Open access bot: url-access updated in citation with #oabot. |
imported>Iztwoz →Pathophysiology: rm unneeded unused abbreviation |
||
| Line 29: | Line 29: | ||
|named after = | |named after = | ||
}} | }} | ||
'''Heartburn''' is a burning sensation felt behind the [[breastbone]]. It is a symptom that is commonly linked to [[acid reflux]] and is often triggered by food | '''Heartburn''' is a burning sensation felt behind the [[breastbone]]. It is a symptom that is commonly linked to [[acid reflux]]{{efn|Acid reflux is when stomach acid travels upward into a person's throat.{{sfn|''Cleveland Clinic''|2023}}}} and is often triggered by food. Lying down, bending, lifting, and performing certain [[exercise]]s can exacerbate heartburn. Causes include acid reflux, [[gastroesophageal reflux disease]] (GERD),{{efn|Gastroesophageal reflux disease (GERD) is a disease in which acid reflux causes symptoms or damage to the esophagus.{{sfn|Fass|Boeckxstaens|El-Serag|Rosen|2021|p=1}} GERD is a chronic form of acid reflux.{{sfn|''Cleveland Clinic''|2023}}}} damage to the esophageal lining, [[bile acid]], mechanical stimulation to the [[esophagus]], and esophageal [[hypersensitivity]]. Heartburn affects 25% of the population at least once a month. | ||
[[Endoscopy]] and [[esophageal pH monitoring]] can be used to evaluate heartburn. Some causes of heartburn, such as GERD, may be diagnosed based on symptoms alone. Potential [[Differential diagnosis|differential diagnoses]] for heartburn include motility disorders, ulcers, [[Esophagitis|inflammation of the esophagus]], and medication [[side effect]]s. Lifestyle changes, such as [[weight loss|losing weight]] and avoiding fatty foods, can improve heartburn. [[Over-the-counter drug|Over-the-counter]] [[alginates]] or [[antacid]]s can help with mild or occasional heartburn. Heartburn treatment primarily involves antisecretory medications like [[H2 receptor antagonists]] (H2RAs) and [[Proton-pump inhibitor|proton-pump inhibitors]] (PPIs). | [[Endoscopy]] and [[esophageal pH monitoring]] can be used to evaluate heartburn. Some causes of heartburn, such as GERD, may be diagnosed based on symptoms alone. Potential [[Differential diagnosis|differential diagnoses]] for heartburn include motility disorders, ulcers, [[Esophagitis|inflammation of the esophagus]], and medication [[side effect]]s. Lifestyle changes, such as [[weight loss|losing weight]] and avoiding fatty foods, can improve heartburn. [[Over-the-counter drug|Over-the-counter]] [[alginates]] or [[antacid]]s can help with mild or occasional heartburn. Heartburn treatment primarily involves antisecretory medications like [[H2 receptor antagonists]] (H2RAs) and [[Proton-pump inhibitor|proton-pump inhibitors]] (PPIs). | ||
| Line 35: | Line 35: | ||
== Definition and symptoms == | == Definition and symptoms == | ||
[[File:Sternum front.png|thumb|upright=0.9|Heartburn is felt behind the sternum{{sfn|Spechler|Souza|2021|p=135}} (red)|alt=Diagram showing the human sternum]] | [[File:Sternum front.png|thumb|upright=0.9|Heartburn is felt behind the sternum{{sfn|Spechler|Souza|2021|p=135}} (red)|alt=Diagram showing the human sternum]] | ||
Heartburn is a burning sensation felt behind the [[breastbone]],{{sfn|Spechler|Souza|2021|p=135}} rising to the [[throat]], and may be associated with an acidic taste.{{sfn|Buchan|2016|p=171}} Heartburn is often associated with [[acid reflux]] or [[Regurgitation (digestion)|regurgitation]].{{sfn|Poitras|Bouin|2022|p=308}}{{sfn|DeVault|2016|p=46}} It is sometimes referred to as indigestion, sour stomach, acid regurgitation, or bitter belching.{{sfn|DeVault|2016|p=46}} Heartburn is | Heartburn is a burning sensation felt behind the [[breastbone]],{{sfn|Spechler|Souza|2021|p=135}} rising to the [[throat]], and may be associated with an acidic taste.{{sfn|Buchan|2016|p=171}} Heartburn is often associated with [[acid reflux]] or [[Regurgitation (digestion)|regurgitation]].{{sfn|Poitras|Bouin|2022|p=308}}{{sfn|DeVault|2016|p=46}} It is sometimes referred to as indigestion, sour stomach, acid regurgitation, or bitter belching.{{sfn|DeVault|2016|p=46}} Heartburn is considered troublesome if mild symptoms occur two or more days a week, or moderate/severe symptoms are present at least once per week.{{sfn|Makowsky|2019|pp=107–108}} | ||
The sensation of heartburn often spreads to the [[neck]], throat, or [[Human back|back]] and is commonly triggered by food. It tends to occur within an hour after eating, especially after a large meal | The sensation of heartburn often spreads to the [[neck]], throat, or [[Human back|back]] and is commonly triggered by food. It tends to occur within an hour after eating, especially after a large meal.{{sfn|DeVault|2016|p=46}} Lying down, especially after eating, can make heartburn worse. Some people find their symptoms more severe when lying on their right side. Nightime heartburn can disrupt sleep and affect daily life. Activities that increase abdominal pressure, like bending, lifting heavy objects, or performing certain [[exercise]]s, can also trigger symptoms. Studies suggest that stress and [[Sleep deprivation|lack of sleep]] may make heartburn feel worse by increasing the body's sensitivity to symptoms.{{sfn|DeVault|2016|p=46}} | ||
Lying down, especially after eating, can make heartburn worse. Some people find their symptoms more severe when lying on their right side. | |||
== Differential diagnoses == | == Differential diagnoses == | ||
| Line 49: | Line 47: | ||
Acid reflux is a common cause of heartburn but is not the only etiology.{{sfn|DeVault|2016|p=47}} A study in 1989 demonstrated this by giving participants [[acid]]ic and [[Base (chemistry)|basic]] solutions;{{sfn|Smith|Opekun|Larkai|Graham|1989|p=683}} the acidic solutions induced heartburn in all participants, though the more basic solution still invoked heartburn in over 40% of the participants. Ambulatory pH monitoring reveals that just a small percentage of acid reflux episodes trigger heartburn.{{sfn|DeVault|2016|p=47}} | Acid reflux is a common cause of heartburn but is not the only etiology.{{sfn|DeVault|2016|p=47}} A study in 1989 demonstrated this by giving participants [[acid]]ic and [[Base (chemistry)|basic]] solutions;{{sfn|Smith|Opekun|Larkai|Graham|1989|p=683}} the acidic solutions induced heartburn in all participants, though the more basic solution still invoked heartburn in over 40% of the participants. Ambulatory pH monitoring reveals that just a small percentage of acid reflux episodes trigger heartburn.{{sfn|DeVault|2016|p=47}} | ||
[[File:Esophagus - moderate GERD, intermed. mag.jpg|thumb| | [[File:Esophagus - moderate GERD, intermed. mag.jpg|thumb|Esophagus with moderate GERD showing dilatation of intercellular spaces|upright=1|alt=Histopathology of GERD]] | ||
[[Nerve endings]] and acid-sensitive [[ion channel]]s in the deepest layer of the esophagus are usually protected by anatomical barriers. However, in gastroesophageal reflux disease (GERD), one of the earliest signs of damage is the development of dilated intercellular spaces | [[Nerve endings]] and acid-sensitive [[ion channel]]s in the deepest layer of the esophagus are usually protected by anatomical barriers. However, in gastroesophageal reflux disease (GERD), one of the earliest signs of damage is the development of dilated intercellular spaces in the [[Epithelium|esophageal lining]]. These spaces weaken the protective barrier, allowing acid and other substances to seep in.{{sfn|Argüero|Sifrim|2024|p=289}}{{sfn|DeVault|2016|p=47}} This triggers [[Nociceptor|pain-sensitive nerves]], which send signals to the [[brain]] and cause the sensation of heartburn.{{sfn|DeVault|2016|p=47}}{{sfn|Patel|Fass|Vaezi|2021|p=1318}} | ||
Esophageal reflux can be classified as acidic (pH < 4), weakly acidic (pH 4–7), or non-acidic (pH > 7) using combined | Esophageal reflux can be classified as acidic (pH < 4), weakly acidic (pH 4–7), or non-acidic (pH > 7) using combined [[impedance–pH monitoring]].{{sfn|Zikos|Clarke|2020|p=42}}{{sfn|DeVault|2016|p=47}} Without [[Proton-pump inhibitor|proton-pump inhibitors]] (PPIs), heartburn symptoms are commonly linked to acid reflux, but about 15% of cases involve weakly acidic reflux. Factors like high reflux reach, low pH, large pH drops, high reflux volume, and slow acid clearance increase the likelihood of symptoms.{{sfn|Argüero|Sifrim|2024|p=287}}{{sfn|DeVault|2016|p=47}} When taking PPIs, heartburn may still occur, with 17–37% of cases linked to non-acidic, usually weakly acidic, reflux.{{sfn|DeVault|2016|p=47}} | ||
[[Bile acid]] rising into the esophagus can cause heartburn, though bile acid is slower and less intense than [[stomach acid]] exposure.{{sfn|DeVault|2016|p=47}}{{sfn|Basnayake|Geeraerts|Pauwels|Koek|2021|pp=756,777}} The mechanism behind bile acid causing heartburn symptoms is thought to be due to bile damaging [[cell membrane]]s and releasing intracellular mediators. Studies monitoring acid and bile reflux together show that they often occur simultaneously.{{sfn|DeVault|2016|p=47}} | [[Bile acid]] rising into the esophagus can cause heartburn, though bile acid is slower and less intense than [[stomach acid]] exposure.{{sfn|DeVault|2016|p=47}}{{sfn|Basnayake|Geeraerts|Pauwels|Koek|2021|pp=756,777}} The mechanism behind bile acid causing heartburn symptoms is thought to be due to bile damaging [[cell membrane]]s and releasing intracellular mediators. Studies monitoring acid and bile reflux together show that they often occur simultaneously.{{sfn|DeVault|2016|p=47}} | ||
| Line 69: | Line 67: | ||
# Persistent symptoms despite effective acid-suppressing treatment. | # Persistent symptoms despite effective acid-suppressing treatment. | ||
# No signs of GERD{{efn|Increased acid exposure time or a strong link between reflux events and symptoms.{{sfn|''Rome Foundation''|2025}}}} or eosinophilic esophagitis as the cause of symptoms. | # No signs of GERD{{efn|Increased acid exposure time or a strong link between reflux events and symptoms.{{sfn|''Rome Foundation''|2025}}}} or eosinophilic esophagitis as the cause of symptoms. | ||
# No major | # No major oesophageal motility disorders present.{{efn|Achalasia/EGJ outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, and absent peristalsis{{sfn|''Rome Foundation''|2025}}}} | ||
To qualify as having a diagnosis of functional heartburn, an individual must meet all diagnostic criteria for the past three months, with symptoms appearing at least twice a week and beginning at least six months before the diagnosis.{{sfn|''Rome Foundation''|2025}} | To qualify as having a diagnosis of functional heartburn, an individual must meet all diagnostic criteria for the past three months, with symptoms appearing at least twice a week and beginning at least six months before the diagnosis.{{sfn|''Rome Foundation''|2025}} | ||
| Line 81: | Line 79: | ||
PPIs reduce stomach acid by blocking an enzyme involved in its production ([[hydrogen potassium ATPase]]), and their effects last much longer than H2RAs—around 16 to 18 hours. They are stronger and do not lose effectiveness over time. However, they do not work immediately and do not fix the root cause of acid reflux; they simply make the refluxed contents less acidic. [[Potassium-competitive acid blocker|Potassium-competitive acid blockers]] (P-CABs) are a newer type of acid-reducing medication that work by blocking hydrogen potassium ATPase. [[Vonoprazan]] is the most researched P-CAB and has been found to be just as effective as PPIs in healing esophagitis and preventing relapses. In more severe cases, it may work even better than PPIs. However, P-CABs have not been more effective than a [[placebo]] for treating symptoms in people with nonerosive reflux disease,{{efn|Symptoms related to acid reflux—such as heartburn or regurgitation—despite there being no visible damage to the esophagus when checked by endoscopy{{sfn|Patel|Fass|Vaezi|2021|p=1314}}}} likely because this condition includes a mix of different underlying issues.{{sfn|Savarino|Marabotto|Zentilin|De Bortoli|2023|p=645}} | PPIs reduce stomach acid by blocking an enzyme involved in its production ([[hydrogen potassium ATPase]]), and their effects last much longer than H2RAs—around 16 to 18 hours. They are stronger and do not lose effectiveness over time. However, they do not work immediately and do not fix the root cause of acid reflux; they simply make the refluxed contents less acidic. [[Potassium-competitive acid blocker|Potassium-competitive acid blockers]] (P-CABs) are a newer type of acid-reducing medication that work by blocking hydrogen potassium ATPase. [[Vonoprazan]] is the most researched P-CAB and has been found to be just as effective as PPIs in healing esophagitis and preventing relapses. In more severe cases, it may work even better than PPIs. However, P-CABs have not been more effective than a [[placebo]] for treating symptoms in people with nonerosive reflux disease,{{efn|Symptoms related to acid reflux—such as heartburn or regurgitation—despite there being no visible damage to the esophagus when checked by endoscopy{{sfn|Patel|Fass|Vaezi|2021|p=1314}}}} likely because this condition includes a mix of different underlying issues.{{sfn|Savarino|Marabotto|Zentilin|De Bortoli|2023|p=645}} | ||
[[Prokinetic agent|Prokinetics]] help clear stomach acid from the esophagus by improving muscle movement and speeding up stomach emptying, which can be slow in some people with GERD. Common prokinetics include [[metoclopramide]], [[domperidone]], [[mosapride]], [[itopride]], and [[prucalopride]]. Since GERD can be a motility issue, these drugs have the potential to address its root cause. However, there is no strong evidence that they effectively treat GERD. They are usually added to PPI treatment for those whose heartburn does not improve with PPIs alone, but their effectiveness in this case is unclear. [[Baclofen]] is a [[GABA receptor agonist|GABA agonist]] that helps reduce reflux by decreasing the relaxations of the lower esophageal sphincter, which are one of the main causes of GERD. However, its use is | [[Prokinetic agent|Prokinetics]] help clear stomach acid from the esophagus by improving muscle movement and speeding up stomach emptying, which can be slow in some people with GERD. Common prokinetics include [[metoclopramide]], [[domperidone]], [[mosapride]], [[itopride]], and [[prucalopride]]. Since GERD can be a motility issue, these drugs have the potential to address its root cause. However, there is no strong evidence that they effectively treat GERD. They are usually added to PPI treatment for those whose heartburn does not improve with PPIs alone, but their effectiveness in this case is unclear. [[Baclofen]] is a [[GABA receptor agonist|GABA agonist]] that helps reduce reflux by decreasing the relaxations of the lower esophageal sphincter, which are one of the main causes of GERD. However, its use is limited and is usually considered only as an add-on treatment for individuals with persistent heartburn despite taking PPIs.{{sfn|Savarino|Marabotto|Zentilin|De Bortoli|2023|p=645}} | ||
== Epidemiology == | == Epidemiology == | ||
| Line 88: | Line 86: | ||
== History == | == History == | ||
[[File:Sedum acre single - Niitvälja.jpg|thumb|upright=1|Stonecrop, a plant historically used for the treatment of heartburn{{sfn|Modlin|Kidd|Lye|2003|p=23}}|alt=Photo of the plant stonecrop]] | [[File:Sedum acre single - Niitvälja.jpg|thumb|upright=1|Stonecrop, a plant historically used for the treatment of heartburn{{sfn|Modlin|Kidd|Lye|2003|p=23}}|alt=Photo of the plant stonecrop]] | ||
Heartburn | Heartburn has often been associated with intense emotions, such as anger or distress.{{sfn|Modlin|Kidd|Lye|2003|p=22}} This belief was challenged as early as 1591 when the term ''{{Not a typo|hartburning}}'' was used to describe epigastric irritation.{{sfn|Benson|Din-Lovinescu|Farooq|2020|pp=61–62}} [[William Shakespeare|Shakespeare]] described heartburn in his play [[Richard III (play)|''The Tragedy of Richard the Third'']] as "A long-continues drudge and heart burning between the Queens kindred and the King's blood".{{sfn|Modlin|Kidd|Lye|2003|p=22}}{{efn|Original text: "A long continued grudge and hearte brennynge betwene the Quenes kinred and the kinges blood".{{sfn|Modlin|Kidd|Lye|2003|p=22}}}} Historical descriptions of heartburn from the 1500s to the 1700s include "a sharpness, soreness of the stomach, heartburning"{{efn|Original text: "a sharpnes, sowernes of stomack, hartburning"{{sfn|Modlin|Kidd|Lye|2003|p=22}}}} and "a sharp gnawing pain at the orifice of the stomach".{{sfn|Modlin|Kidd|Lye|2003|p=22}} Throughout the 1500s to the 1800s, [[stonecrop]], chewed [[green tea]], and [[chalk]] or magnesia were reportedly used by some as remedies for heartburn.{{sfn|Modlin|Kidd|Lye|2003|p=23}}{{sfn|Benson|Din-Lovinescu|Farooq|2020|p=62}} | ||
Because the pain was felt in the [[chest]] and the focus was on the heart at the time, doctors initially believed heartburn came from the [[heart]] rather than the esophagus. This is why the terms | Because the pain was felt in the [[chest]] and the focus was on the heart at the time, doctors initially believed heartburn came from the [[heart]] rather than the esophagus. This is why the terms ''cardialgia'' or ''cardialgy'' were first used to describe heartburn.{{sfn|Modlin|Kidd|Lye|2003|p=23}} Symptoms of heartburn were also attributed to the consumption of "poor quality food".{{sfn|Modlin|Kidd|Lye|2003|p=23}}{{sfn|Benson|Din-Lovinescu|Farooq|2020|p=62}} | ||
Throughout the 1700s to the 1800s, many different terms were used to describe acid reflux. An English dictionary from the mid-1700s defined cardialgia as "from ''cardia'', the heart, or rather the left orifice of the stomach, and ''-algia'', to be pained, the pain of the mouth of the stomach or heart-burn".{{sfn|Rameau|Mudry|2020|p=4}} | Throughout the 1700s to the 1800s, many different terms were used to describe acid reflux. An English dictionary from the mid-1700s defined ''cardialgia'' as "from ''cardia'', the heart, or rather the left orifice of the stomach, and ''-algia'', to be pained, the pain of the mouth of the stomach or heart-burn".{{sfn|Rameau|Mudry|2020|p=4}} | ||
Throughout history, the terms cardialgia, heartburn, pyrosis, dyspepsia, and indigestion were often used interchangeably and there was little advancement in differentiating the terms till the 1900s.{{sfn|Rameau|Mudry|2020|p=5}} | Throughout history, the terms ''cardialgia'', ''heartburn'', ''pyrosis'', ''dyspepsia'', and ''indigestion'' were often used interchangeably and there was little advancement in differentiating the terms till the 1900s.{{sfn|Rameau|Mudry|2020|p=5}} | ||
== In pregnancy == | == In pregnancy == | ||
| Line 118: | Line 116: | ||
* {{cite journal | last1=Barish | first1=Charles F. | last2=Castell | first2=Donald O. | last3=Richter | first3=Joel E. | title=Graded esophageal balloon distention: A new provocative test for noncardiac chest pain | journal=[[Digestive Diseases and Sciences]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] | volume=31 | issue=12 | date=December 1986 | issn=0163-2116 | doi=10.1007/BF01299805 | pages=1292–1298| pmid=3803130 }} | * {{cite journal | last1=Barish | first1=Charles F. | last2=Castell | first2=Donald O. | last3=Richter | first3=Joel E. | title=Graded esophageal balloon distention: A new provocative test for noncardiac chest pain | journal=[[Digestive Diseases and Sciences]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] | volume=31 | issue=12 | date=December 1986 | issn=0163-2116 | doi=10.1007/BF01299805 | pages=1292–1298| pmid=3803130 }} | ||
* {{Cite journal |last1=Basnayake |first1=Chamara |last2=Geeraerts |first2=Annelies |last3=Pauwels |first3=Ans |last4=Koek |first4=Ger |last5=Vaezi |first5=Michael |last6=Vanuytsel |first6=Tim |last7=Tack |first7=Jan |date=September 2021 |title=Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment |url=http://minerva-access.unimelb.edu.au/bitstreams/724a8a5e-a24f-5832-8ae3-97b90d8a4732/download |journal=[[Alimentary Pharmacology & Therapeutics]] |publisher=[[Wiley (publisher)|Wiley]] |volume=54 |issue=6 |pages=755–778 |doi=10.1111/apt.16533 |issn=0269-2813 |pmid=34313333 |access-date=March 3, 2025 |doi-access=free|url-access=subscription }} | * {{Cite journal |last1=Basnayake |first1=Chamara |last2=Geeraerts |first2=Annelies |last3=Pauwels |first3=Ans |last4=Koek |first4=Ger |last5=Vaezi |first5=Michael |last6=Vanuytsel |first6=Tim |last7=Tack |first7=Jan |date=September 2021 |title=Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment |url=http://minerva-access.unimelb.edu.au/bitstreams/724a8a5e-a24f-5832-8ae3-97b90d8a4732/download |journal=[[Alimentary Pharmacology & Therapeutics]] |publisher=[[Wiley (publisher)|Wiley]] |volume=54 |issue=6 |pages=755–778 |doi=10.1111/apt.16533 |issn=0269-2813 |pmid=34313333 |access-date=March 3, 2025 |doi-access=free|url-access=subscription }} | ||
* {{cite book | | * {{cite book | last1=Benson | first1=Brian | last2=Din-Lovinescu | first2=Corina | last3=Farooq | first3=Muhammad | title=Laryngopharyngeal and Gastroesophageal Reflux | chapter=A Brief History of Reflux Disease | publisher=[[Springer International Publishing]] | date=2020 | isbn=978-3-030-48889-5 | doi=10.1007/978-3-030-48890-1_8 |pages=61–70 }} | ||
* {{Cite book |last=Buchan |first=Jessica |title=Essential Primary Care |date=May 2, 2016 |publisher=[[Wiley (publisher)|Wiley]] |isbn=978-1-394-32213-8 |pages=170–176 |chapter=Heartburn and dyspepsia |doi=10.1002/9781394322138.ch19}} | * {{Cite book |last=Buchan |first=Jessica |title=Essential Primary Care |date=May 2, 2016 |publisher=[[Wiley (publisher)|Wiley]] |isbn=978-1-394-32213-8 |pages=170–176 |chapter=Heartburn and dyspepsia |doi=10.1002/9781394322138.ch19}} | ||
* {{cite journal | last1=Cook | first1=Chad E. | last2=Décary | first2=Simon | title=Higher order thinking about differential diagnosis | journal=Brazilian Journal of Physical Therapy |publisher=[[Elsevier]] | volume=24 | issue=1 | date=January 2020 | pmid=30723033 | pmc=6994315 | doi=10.1016/j.bjpt.2019.01.010 |issn=1413-3555 | doi-access=free | pages=1–7 }} | * {{cite journal | last1=Cook | first1=Chad E. | last2=Décary | first2=Simon | title=Higher order thinking about differential diagnosis | journal=Brazilian Journal of Physical Therapy |publisher=[[Elsevier]] | volume=24 | issue=1 | date=January 2020 | pmid=30723033 | pmc=6994315 | doi=10.1016/j.bjpt.2019.01.010 |issn=1413-3555 | doi-access=free | pages=1–7 }} | ||
| Line 124: | Line 122: | ||
* {{Cite journal |last1=Domingues |first1=Gerson |last2=Moraes-Filho |first2=Joaquim Prado P. |last3=Fass |first3=Ronnie |date=March 2018 |title=Refractory Heartburn: A Challenging Problem in Clinical Practice |journal=[[Digestive Diseases and Sciences]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] |volume=63 |issue=3 |pages=577–582 |doi=10.1007/s10620-018-4927-5 |issn=0163-2116 |pmid=29352757}} | * {{Cite journal |last1=Domingues |first1=Gerson |last2=Moraes-Filho |first2=Joaquim Prado P. |last3=Fass |first3=Ronnie |date=March 2018 |title=Refractory Heartburn: A Challenging Problem in Clinical Practice |journal=[[Digestive Diseases and Sciences]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] |volume=63 |issue=3 |pages=577–582 |doi=10.1007/s10620-018-4927-5 |issn=0163-2116 |pmid=29352757}} | ||
* {{cite journal | last1=Fass | first1=Ronnie | last2=Boeckxstaens | first2=Guy E. | last3=El-Serag | first3=Hashem | last4=Rosen | first4=Rachel | last5=Sifrim | first5=Daniel | last6=Vaezi | first6=Michael F. | title=Gastro-oesophageal reflux disease | journal=[[Nature Reviews Disease Primers]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] | volume=7 | issue=1 | date=July 29, 2021 | page=55 | issn=2056-676X | doi=10.1038/s41572-021-00287-w | doi-access=free | pmid=34326345 | url=https://lirias.kuleuven.be/bitstream/123456789/680181/2/Nature%202019-20%20%283%29%20no%20red.docx | access-date=2025-03-30| url-access=subscription }} | * {{cite journal | last1=Fass | first1=Ronnie | last2=Boeckxstaens | first2=Guy E. | last3=El-Serag | first3=Hashem | last4=Rosen | first4=Rachel | last5=Sifrim | first5=Daniel | last6=Vaezi | first6=Michael F. | title=Gastro-oesophageal reflux disease | journal=[[Nature Reviews Disease Primers]] |publisher=[[Springer Science+Business Media|Springer Science and Business Media]] | volume=7 | issue=1 | date=July 29, 2021 | page=55 | issn=2056-676X | doi=10.1038/s41572-021-00287-w | doi-access=free | pmid=34326345 | url=https://lirias.kuleuven.be/bitstream/123456789/680181/2/Nature%202019-20%20%283%29%20no%20red.docx | access-date=2025-03-30| url-access=subscription }} | ||
* {{cite journal | | * {{cite journal | last1=Garg | first1=Vandana | last2=Narang | first2=Prashant | last3=Taneja | first3=Ritu | title=Antacids revisited: review on contemporary facts and relevance for self-management | journal=Journal of International Medical Research |publisher=[[SAGE Publications]] | volume=50 | issue=3 | date=March 2022 | issn=0300-0605 | pmid=35343261 | pmc=8966100 | doi=10.1177/03000605221086457 | doi-access=free |pages=1–22 }} | ||
* {{Cite journal |last1=Modlin |first1=Irvin M |last2=Kidd |first2=Mark |last3=Lye |first3=Kevin D |year=2003 |title=Historical perspectives on the treatment of gastroesophageal reflux disease |url=https://www.giendo.theclinics.com/article/S1052-5157(02)00104-6/fulltext |journal=Gastrointestinal Endoscopy Clinics of North America |publisher=[[Elsevier]] |volume=13 |issue=1 |pages=19–55 |doi=10.1016/S1052-5157(02)00104-6 |issn=1052-5157 |pmid=12797425 |access-date=March 9, 2025|url-access=subscription }} | * {{Cite journal |last1=Modlin |first1=Irvin M |last2=Kidd |first2=Mark |last3=Lye |first3=Kevin D |year=2003 |title=Historical perspectives on the treatment of gastroesophageal reflux disease |url=https://www.giendo.theclinics.com/article/S1052-5157(02)00104-6/fulltext |journal=Gastrointestinal Endoscopy Clinics of North America |publisher=[[Elsevier]] |volume=13 |issue=1 |pages=19–55 |doi=10.1016/S1052-5157(02)00104-6 |issn=1052-5157 |pmid=12797425 |access-date=March 9, 2025|url-access=subscription }} | ||
* {{Cite journal |last1=Fass |first1=Ronnie |last2=Zerbib |first2=Frank |last3=Gyawali |first3=C. Prakash |date=June 2020 |title=AGA Clinical Practice Update on Functional Heartburn: Expert Review |url=https://www.gastrojournal.org/article/S0016-5085(20)30128-1/fulltext |journal=[[Gastroenterology (journal)|Gastroenterology]] |publisher=[[Elsevier]] |volume=158 |issue=8 |pages=2286–2293 |doi=10.1053/j.gastro.2020.01.034 |issn=0016-5085 |pmid=32017911 |access-date=March 9, 2025|url-access=subscription }} | * {{Cite journal |last1=Fass |first1=Ronnie |last2=Zerbib |first2=Frank |last3=Gyawali |first3=C. Prakash |date=June 2020 |title=AGA Clinical Practice Update on Functional Heartburn: Expert Review |url=https://www.gastrojournal.org/article/S0016-5085(20)30128-1/fulltext |journal=[[Gastroenterology (journal)|Gastroenterology]] |publisher=[[Elsevier]] |volume=158 |issue=8 |pages=2286–2293 |doi=10.1053/j.gastro.2020.01.034 |issn=0016-5085 |pmid=32017911 |access-date=March 9, 2025|url-access=subscription }} | ||
* {{Cite book |last=Makowsky |first=Mark |title=Patient Assessment in Clinical Pharmacy |date=2019 |publisher=[[Springer International Publishing]] |isbn=978-3-030-11774-0 |pages=107–120 |chapter=Heartburn |doi=10.1007/978-3-030-11775-7_9}} | * {{Cite book |last=Makowsky |first=Mark |title=Patient Assessment in Clinical Pharmacy |date=2019 |publisher=[[Springer International Publishing]] |isbn=978-3-030-11774-0 |pages=107–120 |chapter=Heartburn |doi=10.1007/978-3-030-11775-7_9}} | ||
* {{Cite journal |last1=Patel |first1=Dhyanesh |last2=Fass |first2=Ronnie |last3=Vaezi |first3=Michael |date=July 2021 |title=Untangling Nonerosive Reflux Disease From Functional Heartburn |url=http://www.cghjournal.org/article/S1542356520304341/pdf |journal=[[Clinical Gastroenterology and Hepatology]] |publisher=[[Elsevier]] |volume=19 |issue=7 |pages=1314–1326 |doi=10.1016/j.cgh.2020.03.057 |issn=1542-3565 |pmid=32246998 |access-date=March 2, 2025 |doi-access=free}} | * {{Cite journal |last1=Patel |first1=Dhyanesh |last2=Fass |first2=Ronnie |last3=Vaezi |first3=Michael |date=July 2021 |title=Untangling Nonerosive Reflux Disease From Functional Heartburn |url=http://www.cghjournal.org/article/S1542356520304341/pdf |journal=[[Clinical Gastroenterology and Hepatology]] |publisher=[[Elsevier]] |volume=19 |issue=7 |pages=1314–1326 |doi=10.1016/j.cgh.2020.03.057 |issn=1542-3565 |pmid=32246998 |access-date=March 2, 2025 |doi-access=free}} | ||
* {{Cite book |last1=Poitras |first1=P. |title=The Digestive System: From Basic Sciences to Clinical Practice |last2=Bouin |first2=M. |date=2022 |publisher=[[Springer International Publishing]] |isbn=978-3-030-98380-2 |chapter=Esophageal Symptoms: Heartburn, Dysphagia, and Chest Pain |doi=10.1007/978-3-030-98381-9_9 |pages= | * {{Cite book |last1=Poitras |first1=P. |title=The Digestive System: From Basic Sciences to Clinical Practice |last2=Bouin |first2=M. |date=2022 |publisher=[[Springer International Publishing]] |isbn=978-3-030-98380-2 |chapter=Esophageal Symptoms: Heartburn, Dysphagia, and Chest Pain |doi=10.1007/978-3-030-98381-9_9 |pages=307–310 }} | ||
* {{Cite journal |last1=Rameau |first1=Anaïs |last2=Mudry |first2=Albert |date=October 2020 |title=When did gastro-esophageal reflux become a disease? A historical perspective on GER(D) nomenclature |journal=[[International Journal of Pediatric Otorhinolaryngology]] |publisher=[[Elsevier]] |volume=137 | | * {{Cite journal |last1=Rameau |first1=Anaïs |last2=Mudry |first2=Albert |date=October 2020 |title=When did gastro-esophageal reflux become a disease? A historical perspective on GER(D) nomenclature |journal=[[International Journal of Pediatric Otorhinolaryngology]] |publisher=[[Elsevier]] |volume=137 |article-number=110214 |doi=10.1016/j.ijporl.2020.110214 |issn=0165-5876 |pmid=32658809}} | ||
* {{Cite book |last=Roman |first=Sabine |title=Clinical and Basic Neurogastroenterology and Motility |date=2020 |publisher=[[Elsevier]] |isbn=978-0-12-813037-7 |pages=225–236 |chapter=Gastro-esophageal reflux disorders |doi=10.1016/b978-0-12-813037-7.00015-7}} | * {{Cite book |last=Roman |first=Sabine |title=Clinical and Basic Neurogastroenterology and Motility |date=2020 |publisher=[[Elsevier]] |isbn=978-0-12-813037-7 |pages=225–236 |chapter=Gastro-esophageal reflux disorders |doi=10.1016/b978-0-12-813037-7.00015-7}} | ||
* {{Cite web |date=February 7, 2025 |title=Rome IV Criteria |url=https://theromefoundation.org/rome-iv/rome-iv-criteria/ |access-date=March 6, 2025 |website=[[Rome Foundation]] |ref={{sfnref|Rome Foundation|2025}}}} | * {{Cite web |date=February 7, 2025 |title=Rome IV Criteria |url=https://theromefoundation.org/rome-iv/rome-iv-criteria/ |access-date=March 6, 2025 |website=[[Rome Foundation]] |ref={{sfnref|Rome Foundation|2025}}}} | ||
Latest revision as of 06:36, 2 November 2025
Template:Short description Script error: No such module "about". Script error: No such module "redirect hatnote". Template:Main other Template:Use mdy dates Template:Infobox medical condition Heartburn is a burning sensation felt behind the breastbone. It is a symptom that is commonly linked to acid refluxTemplate:Efn and is often triggered by food. Lying down, bending, lifting, and performing certain exercises can exacerbate heartburn. Causes include acid reflux, gastroesophageal reflux disease (GERD),Template:Efn damage to the esophageal lining, bile acid, mechanical stimulation to the esophagus, and esophageal hypersensitivity. Heartburn affects 25% of the population at least once a month.
Endoscopy and esophageal pH monitoring can be used to evaluate heartburn. Some causes of heartburn, such as GERD, may be diagnosed based on symptoms alone. Potential differential diagnoses for heartburn include motility disorders, ulcers, inflammation of the esophagus, and medication side effects. Lifestyle changes, such as losing weight and avoiding fatty foods, can improve heartburn. Over-the-counter alginates or antacids can help with mild or occasional heartburn. Heartburn treatment primarily involves antisecretory medications like H2 receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs).
Definition and symptoms
Heartburn is a burning sensation felt behind the breastbone,Template:Sfn rising to the throat, and may be associated with an acidic taste.Template:Sfn Heartburn is often associated with acid reflux or regurgitation.Template:SfnTemplate:Sfn It is sometimes referred to as indigestion, sour stomach, acid regurgitation, or bitter belching.Template:Sfn Heartburn is considered troublesome if mild symptoms occur two or more days a week, or moderate/severe symptoms are present at least once per week.Template:Sfn
The sensation of heartburn often spreads to the neck, throat, or back and is commonly triggered by food. It tends to occur within an hour after eating, especially after a large meal.Template:Sfn Lying down, especially after eating, can make heartburn worse. Some people find their symptoms more severe when lying on their right side. Nightime heartburn can disrupt sleep and affect daily life. Activities that increase abdominal pressure, like bending, lifting heavy objects, or performing certain exercises, can also trigger symptoms. Studies suggest that stress and lack of sleep may make heartburn feel worse by increasing the body's sensitivity to symptoms.Template:Sfn
Differential diagnoses
The differential diagnosis, a process used by healthcare professionals to help differentiate a diagnosis from other similar disorders,Template:Sfn for heartburn includes motility disorders such as achalasia and gastroparesis; peptic ulcers; functional dyspepsia; angina;Template:Sfn eosinophilic esophagitis; coronary artery disease; functional heartburn;Template:Sfn peristalsis; acid reflux; inflammation of the esophagus (esophagitis), stomach (gastritis), pancreas (pancreatitis), gallbladder (cholecystitis), and duodenum (duodenitis); esophageal cancer; ischemic pain; hiatal hernia; biliary colic; stomach cancer; gallstones; pancreatic cancer; duodenal ulcer; and mesenteric adenitis.Template:Sfn Heartburn can also be caused by certain medications such as nonsteroidal anti‐inflammatory drugs, corticosteroids, tetracycline antibiotics, bisphosphonates, calcium‐channel blockers, nitrates, tricyclic antidepressants, and anticholinergics.Template:Sfn
Pathophysiology
The exact causes of heartburn are not fully understood, but they likely involve multiple factors, including chemical irritation, pressure on the esophagus, and increased sensitivity to pain.Template:Sfn
Acid reflux is a common cause of heartburn but is not the only etiology.Template:Sfn A study in 1989 demonstrated this by giving participants acidic and basic solutions;Template:Sfn the acidic solutions induced heartburn in all participants, though the more basic solution still invoked heartburn in over 40% of the participants. Ambulatory pH monitoring reveals that just a small percentage of acid reflux episodes trigger heartburn.Template:Sfn
Nerve endings and acid-sensitive ion channels in the deepest layer of the esophagus are usually protected by anatomical barriers. However, in gastroesophageal reflux disease (GERD), one of the earliest signs of damage is the development of dilated intercellular spaces in the esophageal lining. These spaces weaken the protective barrier, allowing acid and other substances to seep in.Template:SfnTemplate:Sfn This triggers pain-sensitive nerves, which send signals to the brain and cause the sensation of heartburn.Template:SfnTemplate:Sfn
Esophageal reflux can be classified as acidic (pH < 4), weakly acidic (pH 4–7), or non-acidic (pH > 7) using combined impedance–pH monitoring.Template:SfnTemplate:Sfn Without proton-pump inhibitors (PPIs), heartburn symptoms are commonly linked to acid reflux, but about 15% of cases involve weakly acidic reflux. Factors like high reflux reach, low pH, large pH drops, high reflux volume, and slow acid clearance increase the likelihood of symptoms.Template:SfnTemplate:Sfn When taking PPIs, heartburn may still occur, with 17–37% of cases linked to non-acidic, usually weakly acidic, reflux.Template:Sfn
Bile acid rising into the esophagus can cause heartburn, though bile acid is slower and less intense than stomach acid exposure.Template:SfnTemplate:Sfn The mechanism behind bile acid causing heartburn symptoms is thought to be due to bile damaging cell membranes and releasing intracellular mediators. Studies monitoring acid and bile reflux together show that they often occur simultaneously.Template:Sfn
Mechanical stimulation may play a role in heartburn. Esophageal balloon distension,Template:Efn especially in the upper esophagus, can trigger heartburn symptoms.Template:SfnTemplate:Sfn This may be because the upper esophagus has more pressure-sensitive receptors than the lower esophagus. Acid exposure may also make these receptors more sensitive.Template:Sfn
Esophageal hypersensitivity plays a major role in heartburn, especially in those with GERD who have normal acid levels. As shown in esophageal balloon studies, these individuals are also more sensitive to mechanical pressure.Template:SfnTemplate:Sfn The likely cause is altered brain processing (central sensitization) rather than issues with esophageal receptors. Anxiety and stress can further heighten heartburn perception, both through brain mechanisms and possibly by weakening the esophageal lining (dilated intercellular spaces).Template:SfnTemplate:Sfn
Diagnostic approach
Diagnostic investigations for the evaluation of heartburn include endoscopy and esophageal pH monitoring. GERD is commonly diagnosed based on symptoms of heartburn or regurgitation. Endoscopy may be used to evaluate people who do not respond to treatment for heartburn or those with alarm symptoms such as persistent vomiting, gastrointestinal bleeding, iron-deficiency anemia, involuntary weight loss, difficult/painful swallowing (dysphagia, odynophagia), epigastric mass, family history of esophageal or gastric cancer, and new onset of symptoms in those older than 50 years of age.Template:Sfn
Endoscopy is a method used to detect abnormalities in the esophageal lining such as erosive esophagitis and Barrett's esophagus. Biopsies taken during an endoscopy can help assess for other conditions linked to heartburn, such as eosinophilic and lymphocytic esophagitis.Template:Sfn The esophageal 24-hour pH test or the multichannel intraluminal impedance-pH test is often performed in those with refractory heartburn who have undergone an endoscopy. High-resolution esophageal manometry (HREM) is the standard test for diagnosing esophageal motor disorders. It helps rule out major motility issues in those with persistent heartburn who have normal endoscopy and pH testing. Motility disorders include achalasia, esophagogastric junction outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, and absent contractility. HREM can also distinguish GERD from conditions like rumination and supra-gastric belching. In some cases, gastric scintigraphy may be used to detect gastroparesis.Template:Sfn
Functional heartburn is a burning feeling behind the breastbone, similar to GERD, but without signs of acid reflux, esophageal motor disorders, or mucosal damage on diagnostic tests like reflux monitoring, manometry, or endoscopy. After tests have been performed to rule out other causes of heartburn, functional heartburn is diagnosed according to diagnostic criteria:Template:SfnTemplate:Sfn
- Burning sensation or pain behind the chest.
- Persistent symptoms despite effective acid-suppressing treatment.
- No signs of GERDTemplate:Efn or eosinophilic esophagitis as the cause of symptoms.
- No major oesophageal motility disorders present.Template:Efn
To qualify as having a diagnosis of functional heartburn, an individual must meet all diagnostic criteria for the past three months, with symptoms appearing at least twice a week and beginning at least six months before the diagnosis.Template:Sfn
Treatment
Lifestyle changes such as losing weight and avoiding fatty, heavy, or spicy foods, particularly before bed, can improve symptoms. Over-the-counter alginates or antacids can be used on an as-needed basis to help with mild or intermittent heartburn. Individuals may aim to stop medications that can make heartburn worse. Physicians sometimes prescribe PPIs for four weeks to treat heartburn. H. pylori, if found, can be treated. If someone does not respond to a PPI, physicians may try H2 receptor antagonists. As a person's symptoms improve, physicians may decrease the frequency or dose of medications.Template:Sfn
Many drugs have been used to treat heartburn, but antisecretory medications such as H2 receptor antagonists and PPIs have the most evidence for the treatment of heartburn.Template:Sfn Low doses of tricyclic antidepressants and selective serotonin reuptake inhibitors may be used to manage functional heartburn.Template:Sfn
Antacids are fast-acting, short-term remedies for heartburn, made from compounds like aluminium hydroxide, magnesium hydroxide, and calcium carbonate, which neutralize acid. While still commonly used today,Template:Sfn antacids were used more often before stronger acid-lowering drugs were discovered, mainly for occasional, post-meal heartburn or as needed.Template:Sfn Alginate, extracted from seaweed and combined with sodium or potassium bicarbonate, is more effective than antacids for heartburn relief. In short-term GERD treatment (four weeks), alginate works as well as PPIs. It is also used as an add-on therapy for people whose symptoms do not fully resolve with PPIs, improving heartburn control and quality of life more than PPIs alone. H2RAs help lower stomach acid by blocking histamine at specific receptors in the stomach lining. Their effect lasts between four and eight hours, depending on the medication. They are mostly used for quick relief in people with mild acid reflux or as an additional treatment alongside PPIs, especially at night since they are better at controlling nighttime acid levels.Template:Sfn
PPIs reduce stomach acid by blocking an enzyme involved in its production (hydrogen potassium ATPase), and their effects last much longer than H2RAs—around 16 to 18 hours. They are stronger and do not lose effectiveness over time. However, they do not work immediately and do not fix the root cause of acid reflux; they simply make the refluxed contents less acidic. Potassium-competitive acid blockers (P-CABs) are a newer type of acid-reducing medication that work by blocking hydrogen potassium ATPase. Vonoprazan is the most researched P-CAB and has been found to be just as effective as PPIs in healing esophagitis and preventing relapses. In more severe cases, it may work even better than PPIs. However, P-CABs have not been more effective than a placebo for treating symptoms in people with nonerosive reflux disease,Template:Efn likely because this condition includes a mix of different underlying issues.Template:Sfn
Prokinetics help clear stomach acid from the esophagus by improving muscle movement and speeding up stomach emptying, which can be slow in some people with GERD. Common prokinetics include metoclopramide, domperidone, mosapride, itopride, and prucalopride. Since GERD can be a motility issue, these drugs have the potential to address its root cause. However, there is no strong evidence that they effectively treat GERD. They are usually added to PPI treatment for those whose heartburn does not improve with PPIs alone, but their effectiveness in this case is unclear. Baclofen is a GABA agonist that helps reduce reflux by decreasing the relaxations of the lower esophageal sphincter, which are one of the main causes of GERD. However, its use is limited and is usually considered only as an add-on treatment for individuals with persistent heartburn despite taking PPIs.Template:Sfn
Epidemiology
About 25% of people experience heartburn at least once a month, while 12% have it at least once a week.Template:Sfn Clinically significant heartburn affects about 6% of the American population.Template:Sfn Most people do not see heartburn as a serious medical issue and rarely seek medical help for it. A survey in Olmsted County, Minnesota, found that only 5.4% of participants with heartburn had addressed their heartburn with a doctor in the past year, even though their symptoms were moderately severe and had lasted for over five years.Template:Sfn
History
Heartburn has often been associated with intense emotions, such as anger or distress.Template:Sfn This belief was challenged as early as 1591 when the term Template:Not a typo was used to describe epigastric irritation.Template:Sfn Shakespeare described heartburn in his play The Tragedy of Richard the Third as "A long-continues drudge and heart burning between the Queens kindred and the King's blood".Template:SfnTemplate:Efn Historical descriptions of heartburn from the 1500s to the 1700s include "a sharpness, soreness of the stomach, heartburning"Template:Efn and "a sharp gnawing pain at the orifice of the stomach".Template:Sfn Throughout the 1500s to the 1800s, stonecrop, chewed green tea, and chalk or magnesia were reportedly used by some as remedies for heartburn.Template:SfnTemplate:Sfn
Because the pain was felt in the chest and the focus was on the heart at the time, doctors initially believed heartburn came from the heart rather than the esophagus. This is why the terms cardialgia or cardialgy were first used to describe heartburn.Template:Sfn Symptoms of heartburn were also attributed to the consumption of "poor quality food".Template:SfnTemplate:Sfn
Throughout the 1700s to the 1800s, many different terms were used to describe acid reflux. An English dictionary from the mid-1700s defined cardialgia as "from cardia, the heart, or rather the left orifice of the stomach, and -algia, to be pained, the pain of the mouth of the stomach or heart-burn".Template:Sfn
Throughout history, the terms cardialgia, heartburn, pyrosis, dyspepsia, and indigestion were often used interchangeably and there was little advancement in differentiating the terms till the 1900s.Template:Sfn
In pregnancy
Heartburn is common in pregnancy, with the incidence ranging between 17% and 45%. Complications related to heartburn in pregnancy are rare, meaning that diagnostic tests such as upper endoscopy are usually not required, and the diagnosis can be made based on symptoms.Template:Sfn
Many different factors lead to the development of heartburn during pregnancy. Hormonal changes, such as higher levels of progesterone, can cause relaxation of the smooth muscles, which lowers stomach tone and motility and reduces pressure in the lower esophageal sphincter.Template:SfnTemplate:Sfn During pregnancy, the lower esophageal sphincter moves into the chest cavity, where pressure is lower. This makes it easier for stomach acid and food to flow back into the esophagus, causing irritation and a burning sensation.Template:Sfn Other factors that can cause heartburn during pregnancy include increased pressure on the stomach from the uterus, weight gain, changes in gastric emptying, delayed small bowel transit, or medications.Template:SfnTemplate:Sfn
See also
Notes
References
Works cited
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
Further reading
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
External links
- Script error: No such module "citation/CS1".
- Script error: No such module "citation/CS1".